Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

25 Jun 2024 07:00

RNS Number : 6762T
Anpario PLC
25 June 2024
 
Anpario plc("Anpario", "Group" or the "Company")

 

AGM Statement

 

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today, at which Matthew Robinson, Chairman, will make the following statement:

 

"The Group has delivered a strong sales performance and a corresponding improvement in profit in the first half of the year as the global agriculture market continues to improve and we are confident of achieving market expectations for the full year. There are still challenges to navigate and as highlighted at the time of our 2023 full year results announcement on 20 March 2024, we expected individual territory performance to be variable. In contrast to the strong first half performances last year in the United States and Australia, both territories have experienced weaker trading in the current period. However, all other regions have delivered strong sales growth with notable performances from Asia Pacific, Middle East and Africa and South America, demonstrating the resilience afforded by our geographic diversity.

 

The Group's business development initiatives are centred around expanding in the ruminant and aquaculture sectors as well as working with several partners in pet food where we can offer natural sustainable solutions. Our unique water-soluble phytogenic product Orego-Stim® Forte, for aquatic species, continues to show excellent field trial results, especially for inhibiting the growth of Vibrio species of bacteria in the absence of antibiotics. As such we are experiencing strong interest for this product from across the aquaculture industry.

 

Raw material prices have stabilised and together with increased volumes through our highly automated production facility we are delivering improved gross margins and profitability. Our cash position has improved further since the year end, with a balance of £12.2m as at 31 May 2024, giving us a strong financial position with which to continue to grow the business, both organically and through acquisitions, should the right opportunities arise."

 

The Company's interim results for the six months period ended 30 June 2024 are expected to be announced on 11 September 2024. 

 

 

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLTREISFIS
Date   Source Headline
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review
17th Jul 200812:15 pmRNSBlocklisting Interim Review
15th Jul 200811:19 amRNSBlocklisting Interim Review
14th Jul 200811:36 amRNSTrading Statement
2nd Jul 20083:07 pmRNSDirectorate Change
13th May 20089:34 amRNSDirectorate Change
13th May 20089:30 amRNSAnglo Platinum CEO
30th Apr 20082:31 pmRNSDividend Declaration
29th Apr 200811:25 amRNSNew order mining rights
29th Apr 200811:03 amRNSMining Rights Conversions
29th Apr 20087:00 amRNSFirst Quarter Review
2nd Apr 20087:00 amRNSFinal Results
11th Mar 20089:43 amRNSDividend conversion rate
10th Mar 20081:04 pmRNSRevised Conversion Price
7th Mar 20081:54 pmRNSDirector/PDMR Shareholding
7th Mar 20089:35 amRNSEmployee Share Scheme
15th Feb 20089:18 amRNSSmelter Shutdown
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSAnglo Platinum
31st Jan 20089:50 amRNSPlatinum Transaction
31st Jan 20089:27 amRNSJoint Transaction
25th Jan 20085:38 pmRNSEnergy Supply Talks
23rd Jan 20082:24 pmRNSInterruption: Mine Production
23rd Jan 200811:07 amRNSDirectorate Change
17th Jan 20089:57 amRNSBlocklisting Interim Review
11th Jan 200812:16 pmRNSBlock listing application
16th Nov 20072:00 pmRNSAnglo Platinum Announcement
16th Nov 20071:56 pmRNSReduction in target
7th Nov 200710:12 amRNSProposed Transactions
2nd Nov 20072:00 pmRNSDirectorate Change
26th Oct 20073:02 pmRNSDividend Declaration
11th Oct 20071:00 pmRNSDirectorate Change
1st Oct 20073:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSInterim Results
4th Sep 20077:01 amRNSNotification
24th Aug 20073:23 pmRNSWage negotiations
22nd Aug 20079:09 amRNSDividend Conversion Rate
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser
30th Jul 200712:43 pmRNSDirectorate Change
30th Jul 20078:00 amRNSInterim Results
30th Jul 20078:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.